 Sharon Hunter
Concepts (137)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Choline | 12 | 2024 | 137 | 3.470 |
Why?
| | Prenatal Exposure Delayed Effects | 9 | 2021 | 650 | 1.910 |
Why?
| | Sensory Gating | 8 | 2024 | 44 | 1.890 |
Why?
| | Fetal Development | 9 | 2024 | 298 | 1.720 |
Why?
| | Evoked Potentials, Auditory | 8 | 2024 | 181 | 1.560 |
Why?
| | Folic Acid | 4 | 2024 | 198 | 1.050 |
Why?
| | Gestational Age | 6 | 2026 | 987 | 0.900 |
Why?
| | Premature Birth | 3 | 2026 | 387 | 0.810 |
Why?
| | Pregnancy Complications, Infectious | 4 | 2021 | 438 | 0.810 |
Why?
| | Pregnancy Complications | 3 | 2021 | 600 | 0.800 |
Why?
| | Mothers | 5 | 2021 | 764 | 0.790 |
Why?
| | Child Development | 6 | 2024 | 483 | 0.740 |
Why?
| | Pregnancy | 18 | 2024 | 7182 | 0.720 |
Why?
| | Fetus | 4 | 2021 | 804 | 0.710 |
Why?
| | Heart Rate, Fetal | 1 | 2021 | 31 | 0.690 |
Why?
| | Electroencephalography | 7 | 2024 | 561 | 0.670 |
Why?
| | Brain | 10 | 2021 | 2934 | 0.640 |
Why?
| | C-Reactive Protein | 3 | 2020 | 422 | 0.580 |
Why?
| | Hallucinogens | 1 | 2021 | 111 | 0.570 |
Why?
| | Nutritional Status | 1 | 2021 | 353 | 0.550 |
Why?
| | Adrenal Cortex Hormones | 1 | 2021 | 483 | 0.550 |
Why?
| | Infant, Newborn | 11 | 2026 | 6435 | 0.480 |
Why?
| | Sleep | 3 | 2015 | 887 | 0.470 |
Why?
| | Infant Behavior | 4 | 2021 | 27 | 0.440 |
Why?
| | Mental Disorders | 2 | 2021 | 1154 | 0.430 |
Why?
| | Inflammation | 3 | 2021 | 2876 | 0.420 |
Why?
| | Evoked Potentials | 1 | 2015 | 131 | 0.400 |
Why?
| | Cannabis | 1 | 2021 | 509 | 0.400 |
Why?
| | Infant | 17 | 2026 | 10060 | 0.390 |
Why?
| | Depression | 3 | 2021 | 1537 | 0.380 |
Why?
| | Schizophrenia | 3 | 2013 | 441 | 0.360 |
Why?
| | Attention | 5 | 2020 | 461 | 0.340 |
Why?
| | Female | 27 | 2026 | 78636 | 0.320 |
Why?
| | Antidepressive Agents | 1 | 2012 | 239 | 0.310 |
Why?
| | Hippocampus | 2 | 2026 | 969 | 0.290 |
Why?
| | Anxiety Disorders | 1 | 2012 | 368 | 0.290 |
Why?
| | Dietary Supplements | 4 | 2021 | 582 | 0.280 |
Why?
| | Acoustic Stimulation | 4 | 2018 | 333 | 0.270 |
Why?
| | Speech Perception | 2 | 2021 | 91 | 0.270 |
Why?
| | Auditory Threshold | 1 | 2008 | 51 | 0.260 |
Why?
| | Prenatal Care | 4 | 2021 | 309 | 0.260 |
Why?
| | Maternal Exposure | 2 | 2019 | 188 | 0.260 |
Why?
| | Psychotic Disorders | 3 | 2021 | 185 | 0.250 |
Why?
| | Child, Preschool | 7 | 2024 | 11835 | 0.250 |
Why?
| | Auditory Perception | 1 | 2008 | 115 | 0.250 |
Why?
| | Humans | 30 | 2026 | 145140 | 0.240 |
Why?
| | Hearing Loss | 2 | 2021 | 249 | 0.230 |
Why?
| | Male | 19 | 2026 | 72664 | 0.210 |
Why?
| | Fatty Acids, Omega-3 | 2 | 2021 | 142 | 0.180 |
Why?
| | Meditation | 1 | 2022 | 34 | 0.180 |
Why?
| | Synaptic Transmission | 1 | 2024 | 291 | 0.170 |
Why?
| | Wechsler Scales | 1 | 2021 | 61 | 0.170 |
Why?
| | Social Problems | 1 | 2021 | 12 | 0.170 |
Why?
| | Pregnancy Trimester, Third | 1 | 2021 | 118 | 0.170 |
Why?
| | Micronutrients | 2 | 2021 | 102 | 0.170 |
Why?
| | Infant, Premature | 1 | 2026 | 619 | 0.170 |
Why?
| | Motor Activity | 1 | 2026 | 718 | 0.170 |
Why?
| | Nutritional Requirements | 1 | 2021 | 78 | 0.170 |
Why?
| | Vitamin D | 2 | 2021 | 403 | 0.160 |
Why?
| | Intelligence | 1 | 2021 | 112 | 0.160 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 2 | 2016 | 427 | 0.160 |
Why?
| | Language Development | 1 | 2021 | 59 | 0.160 |
Why?
| | Models, Neurological | 1 | 2002 | 250 | 0.150 |
Why?
| | alpha7 Nicotinic Acetylcholine Receptor | 3 | 2015 | 94 | 0.150 |
Why?
| | Visual Perception | 1 | 2002 | 183 | 0.150 |
Why?
| | Reaction Time | 2 | 2015 | 431 | 0.150 |
Why?
| | Mindfulness | 1 | 2022 | 136 | 0.150 |
Why?
| | Phosphatidylcholines | 2 | 2018 | 130 | 0.140 |
Why?
| | Hydrocortisone | 1 | 2020 | 298 | 0.140 |
Why?
| | Developmental Disabilities | 1 | 2021 | 281 | 0.130 |
Why?
| | Nootropic Agents | 2 | 2020 | 30 | 0.130 |
Why?
| | Adult | 8 | 2024 | 40665 | 0.130 |
Why?
| | Cognition | 1 | 2026 | 1262 | 0.130 |
Why?
| | Betacoronavirus | 1 | 2020 | 287 | 0.130 |
Why?
| | Primary Prevention | 1 | 2018 | 218 | 0.120 |
Why?
| | Marijuana Smoking | 1 | 2019 | 249 | 0.120 |
Why?
| | Pandemics | 2 | 2021 | 1703 | 0.110 |
Why?
| | Magnetic Resonance Imaging | 2 | 2026 | 3892 | 0.110 |
Why?
| | Placenta | 1 | 2021 | 784 | 0.100 |
Why?
| | Reproducibility of Results | 2 | 2015 | 3410 | 0.100 |
Why?
| | Child Behavior | 1 | 2015 | 236 | 0.100 |
Why?
| | Risk Factors | 3 | 2021 | 10857 | 0.100 |
Why?
| | Phosphorylcholine | 1 | 2013 | 19 | 0.100 |
Why?
| | Stress, Psychological | 3 | 2022 | 1145 | 0.090 |
Why?
| | Neural Inhibition | 1 | 2013 | 178 | 0.090 |
Why?
| | Maternal Behavior | 1 | 2011 | 84 | 0.080 |
Why?
| | Mother-Child Relations | 1 | 2011 | 131 | 0.080 |
Why?
| | Receptors, Cholinergic | 1 | 2009 | 41 | 0.080 |
Why?
| | Tobacco Use Disorder | 1 | 2010 | 216 | 0.070 |
Why?
| | Random Allocation | 1 | 2008 | 365 | 0.060 |
Why?
| | Self Report | 1 | 2011 | 867 | 0.060 |
Why?
| | Motivation | 1 | 2011 | 600 | 0.060 |
Why?
| | Signal Processing, Computer-Assisted | 2 | 2021 | 152 | 0.060 |
Why?
| | Child | 3 | 2021 | 22670 | 0.060 |
Why?
| | Connectome | 1 | 2026 | 93 | 0.050 |
Why?
| | Follow-Up Studies | 2 | 2013 | 5411 | 0.050 |
Why?
| | Longitudinal Studies | 2 | 2026 | 2949 | 0.050 |
Why?
| | Anxiety | 2 | 2022 | 1117 | 0.040 |
Why?
| | Eye Movements | 1 | 2002 | 94 | 0.040 |
Why?
| | Vitamin A | 1 | 2021 | 60 | 0.040 |
Why?
| | Animals | 2 | 2021 | 37952 | 0.040 |
Why?
| | Neurons | 2 | 2019 | 1644 | 0.040 |
Why?
| | Object Attachment | 1 | 2020 | 48 | 0.040 |
Why?
| | Vitamins | 1 | 2021 | 182 | 0.040 |
Why?
| | Genotype | 2 | 2015 | 1844 | 0.040 |
Why?
| | Pituitary-Adrenal System | 1 | 2020 | 164 | 0.040 |
Why?
| | Receptors, Nicotinic | 2 | 2013 | 326 | 0.040 |
Why?
| | Hypothalamo-Hypophyseal System | 1 | 2020 | 199 | 0.040 |
Why?
| | Maternal Age | 1 | 2019 | 127 | 0.040 |
Why?
| | Hearing Tests | 1 | 2018 | 53 | 0.030 |
Why?
| | Young Adult | 3 | 2019 | 14176 | 0.030 |
Why?
| | Time Factors | 1 | 2008 | 7107 | 0.030 |
Why?
| | Urinary Tract Infections | 1 | 2019 | 210 | 0.030 |
Why?
| | Pilot Projects | 1 | 2022 | 1889 | 0.030 |
Why?
| | Child Behavior Disorders | 1 | 2016 | 118 | 0.030 |
Why?
| | Brain Diseases | 1 | 2016 | 154 | 0.030 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 388 | 0.030 |
Why?
| | Problem Behavior | 1 | 2016 | 101 | 0.030 |
Why?
| | Coronavirus Infections | 1 | 2020 | 382 | 0.030 |
Why?
| | Respiratory Tract Infections | 1 | 2019 | 394 | 0.030 |
Why?
| | Prospective Studies | 2 | 2019 | 8035 | 0.020 |
Why?
| | Perinatal Care | 1 | 2013 | 59 | 0.020 |
Why?
| | DNA Mutational Analysis | 1 | 2013 | 407 | 0.020 |
Why?
| | Double-Blind Method | 1 | 2015 | 2057 | 0.020 |
Why?
| | Neuropsychological Tests | 1 | 2013 | 1134 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2019 | 5886 | 0.020 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2013 | 1742 | 0.010 |
Why?
| | Family | 1 | 2009 | 682 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2013 | 2351 | 0.010 |
Why?
| | Genetic Linkage | 1 | 2005 | 271 | 0.010 |
Why?
| | Genetic Markers | 1 | 2005 | 333 | 0.010 |
Why?
| | Early Diagnosis | 1 | 2005 | 251 | 0.010 |
Why?
| | Gene Frequency | 1 | 2005 | 484 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2009 | 4552 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2011 | 6055 | 0.010 |
Why?
| | Biomarkers | 1 | 2005 | 4282 | 0.010 |
Why?
| | Mice | 1 | 2009 | 18303 | 0.010 |
Why?
|
|
Hunter's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|